Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Elite Execution Gaming PCs for Gamers- Vote In favor of Your Favored Video Conferencing Administration
- Insane Realities That Will Make You Reconsider How you might interpret History
- Michael Jordan donates $10M to North Carolina medical center in honor of his mother
- Involved Vehicles for Seniors: Track down the Best Picks for Solace and Dependability
- Doctors looking into hormone therapy as a way to ward off dementia in women
- Dominating Online Entertainment Showcasing: 7 Hints for Organizations
- Europe pledges over €15bn for clean energy for Africa
- Green Inflections: A Manual for Inside Plants
